Increasing the activity of monoclonal antibody therapeutics by continuous chromatography (MCSGP)
暂无分享,去创建一个
M. Morbidelli | G. Ströhlein | M Krättli | M Morbidelli | M. Krättli | T Müller-Späth | G Ströhlein | L Aumann | T. Müller-Späth | L. Aumann
[1] Gary Walsh,et al. Biopharmaceuticals: recent approvals and likely directions. , 2005, Trends in biotechnology.
[2] N Avdalovic,et al. Protein variant separations by cation-exchange chromatography on tentacle-type polymeric stationary phases. , 1998, Journal of chromatography. A.
[3] Massimo Morbidelli,et al. Parametric study of a 6‐column countercurrent solvent gradient purification (MCSGP) unit , 2007, Biotechnology and bioengineering.
[4] Roy Jefferis,et al. Glycosylation as a strategy to improve antibody-based therapeutics , 2009, Nature Reviews Drug Discovery.
[5] Terrance A Stadheim,et al. Challenges in therapeutic glycoprotein production. , 2006, Current opinion in biotechnology.
[6] Li Yang,et al. Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion. , 2007, Analytical biochemistry.
[7] Anita M. Katti,et al. Fundamentals of Preparative and Nonlinear Chromatography , 1994 .
[8] B. Kabakoff,et al. Identification of multiple sources of charge heterogeneity in a recombinant antibody. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[9] Massimo Morbidelli,et al. A semicontinuous 3-column countercurrent solvent gradient purification (MCSGP) process. , 2008, Biotechnology and bioengineering.
[10] M. Butler,et al. Comparisons of the Glycosylation of a Monoclonal Antibody Produced under Nominally Identical Cell Culture Conditions in Two Different Bioreactors , 2000, Biotechnology progress.
[11] Uwe Kärst,et al. Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24. , 2003, Biotechnology and bioengineering.
[12] Gregory C Flynn,et al. Human antibody Fc deamidation in vivo. , 2009, Biologicals : journal of the International Association of Biological Standardization.
[13] Alain Beck,et al. Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody. , 2009, Analytical biochemistry.
[14] Massimo Morbidelli,et al. A continuous, counter-current multi-column chromatographic process incorporating modifier gradients for ternary separations. , 2006, Journal of chromatography. A.
[15] Massimo Morbidelli,et al. Chromatographic separation of three monoclonal antibody variants using multicolumn countercurrent solvent gradient purification (MCSGP) , 2008, Biotechnology and Bioengineering.
[16] B. Yan,et al. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain. , 2009, Journal of pharmaceutical sciences.
[17] Manfred Morari,et al. Optimizing model predictive control of the chromatographic multi-column solvent gradient purification (MCSGP) process , 2010 .
[18] Massimo Morbidelli,et al. A continuous multicolumn countercurrent solvent gradient purification (MCSGP) process , 2007, Biotechnology and bioengineering.
[19] G. Guiochon,et al. Determination of the lumped mass transfer rate coefficient by frontal analysis. , 2000, Journal of chromatography. A.
[20] Tyler Carlage,et al. Application of imaging capillary IEF for characterization and quantitative analysis of recombinant protein charge heterogeneity , 2008, Electrophoresis.
[21] Massimo Morbidelli,et al. Role of Cleaning-in-Place in the Purification of mAb Supernatants Using Continuous Cation Exchange Chromatography , 2009 .
[22] M. Morbidelli,et al. Two step capture and purification of IgG2 using multicolumn countercurrent solvent gradient purification (MCSGP) , 2010, Biotechnology and bioengineering.